Inside Johnson & Johnson's 'lightning speed' effort to create a Covid-19 vaccine

Johnson & Johnson is a key player in the global race to develop a new coronavirus vaccine. Advisory Board's Brandi Greenberg and Pam Divack recently spoke with Seema Kumar, Vice President of Innovation, Global Health, and Policy Communication at Johnson & Johnson, who highlighted the three key forces driving the company's progress and explained how Johnson & Johnson is educating the general public about its work.

Read More

Is 'quarantine fatigue' leading America to reopen too soon?

After more than a month of social distancing, some Americans are experiencing "quarantine fatigue." Some people are taking to the streets to protest so-called "stay-at-home" orders—and some states are taking steps to ease those restrictions, even though they haven't achieved metrics called for by public health officials.

Why America's Covid-19 death toll may be much higher than we think

The number of reported U.S. deaths tied to the new coronavirus surpassed 50,000 as of Tuesday morning, but new data suggests that figure might be a drastic undercount.

Around the nation: Oklahoma becomes 1st state to submit waiver seeking Medicaid block grant

Oklahoma Gov. Kevin Stitt (R) last week submitted a waiver request seeking CMS' permission to expand the state's Medicaid program and transition the federal portion of the state's Medicaid funding to a type of block grant, in today's bite-sized hospital and health industry news from California, New York, and Oklahoma.

Covid-19 patients in their 30s and 40s are dying suddenly from strokes

Doctors throughout America are reporting that patients in their 30s and 40s with Covid-19 are experiencing strokes at a higher rate than non-Covid-19 patients in their age group. Advisory Board's Alice Thornton Bell notes that while the new data is "scary," it highlights the importance of accessing stroke care quickly.

The 2019-2020 flu season, charted

America's current flu season appears to be waning, as the latest CDC data shows no states experienced widespread flu activity in the week ending on April 18.